Lifecore Biomedical Inc LFCR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LFCR is a good fit for your portfolio.
News
-
Lifecore Biomedical Completes Incremental Liquidity Initiatives
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
-
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
-
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
-
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Trading Information
- Previous Close Price
- $5.87
- Day Range
- $5.83–6.00
- 52-Week Range
- $4.50–11.46
- Bid/Ask
- $5.31 / $6.13
- Market Cap
- $181.30 Mil
- Volume/Avg
- 219,996 / 200,947
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.72
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 459
- Website
- https://www.lifecore.com
Comparables
Valuation
|
Metric
|
LFCR
|
000739
|
301089
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 17.72 | 20.26 |
Price/Book Value | — | 2.85 | 3.09 |
Price/Sales | 1.72 | 1.58 | 11.99 |
Price/Cash Flow | — | 16.82 | — |
Price/Earnings
LFCR
000739
301089
Financial Strength
|
Metric
|
LFCR
|
000739
|
301089
|
|---|---|---|---|
Quick Ratio | 1.22 | — | 3.18 |
Current Ratio | 2.39 | — | 4.56 |
Interest Coverage | −2.63 | — | −1,600.44 |
Quick Ratio
LFCR
000739
301089
Profitability
|
Metric
|
LFCR
|
000739
|
301089
|
|---|---|---|---|
Return on Assets (Normalized) | −8.68% | 8.04% | −3.77% |
Return on Equity (Normalized) | −39.95% | 17.08% | −4.33% |
Return on Invested Capital (Normalized) | −4.61% | 13.90% | −4.49% |
Return on Assets
LFCR
000739
301089
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Sbzdjbngbs | Shk | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Vctzvjnc | Vppmhy | $79.0 Bil | |
HLN
| Haleon PLC ADR | Hzxdzbbz | Wgb | $38.5 Bil | |
VTRS
| Viatris Inc | Kqkftyft | Gsyx | $13.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ttbnqnxrh | Wzjr | $11.6 Bil | |
CTLT
| Catalent Inc | Pcmvrdhmj | Gkxjqxm | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Tbjsnzq | Hcz | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Kygsvdrg | Hgpdx | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hldgcthv | Clwxlwk | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Cxsklgqm | Mjnn | $3.1 Bil |